Diferencia entre revisiones de «Template:CMV retinitis treatment»
Sin resumen de edición |
(Prepared the page for translation) |
||
| Línea 1: | Línea 1: | ||
<languages/> | |||
<translate> | |||
====Severe Vision Threatening==== | ====Severe Vision Threatening==== | ||
*Ganciclovir intraocular implant for 8 months AND | *Ganciclovir intraocular implant for 8 months AND | ||
**Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days | **Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days | ||
====Peripheral lesions==== | ====Peripheral lesions==== | ||
*Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days | *Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days | ||
</translate> | |||
Revisión del 06:45 26 ene 2026
Severe Vision Threatening
- Ganciclovir intraocular implant for 8 months AND
- Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days
Peripheral lesions
- Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days